TrialThe Lancet. Oncology2016

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.

Daniel R Gomez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.